GB221
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GB221, covering 2019-11-15 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Study of Safety, Tolerability and Efficacy of GB221 in Infants With Spinal Muscular Atrophy Type 1 [Phase 1, Phase 2]